Yi-Ding Chu

Title: Yi-Ding Chu: Innovator in Hepatitis B Research

Introduction

Yi-Ding Chu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the isolation of hepatitis B surface antigens. His innovative methods have the potential to enhance the recovery of important proteins used in medical research and vaccine development.

Latest Patents

Yi-Ding Chu holds a patent for the "Isolation of Hepatitis B surface antigen from transformed yeast cells." This patent describes a method for recovering hepatitis B surface antigen protein from transformed yeast cells. The process includes several steps: obtaining an aqueous homogenate of the yeast cells, enriching the hepatitis B surface antigen protein in the homogenate with a protein-aggregating reagent to form a precipitate, dissolving the precipitate in a buffer to create a suspension, and post-homogenizing the suspension to achieve a yield increase of 10% to 50% compared to methods that do not include the post-homogenizing step. He has 1 patent to his name.

Career Highlights

Yi-Ding Chu is affiliated with the Development Center for Biotechnology, where he continues to advance his research in the field. His work has been instrumental in developing methods that could lead to better treatments and vaccines for hepatitis B.

Collaborations

Some of his notable coworkers include Wei-Kuang Chi and Jih-Han Hsieh. Their collaborative efforts contribute to the ongoing research and development in biotechnology.

Conclusion

Yi-Ding Chu's innovative work in isolating hepatitis B surface antigens showcases his dedication to advancing medical research. His contributions are vital for the development of effective treatments and vaccines, highlighting the importance of innovation in biotechnology.